Author

Jenny A. Jaramillo-Gómez

University of Colorado AnschutzORCID 0009-0005-6416-0948Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

Diana M. CittellyiD· 3 shared Maria Jose Contreras-ZarateiD· 3 shared Ricaurte Alejandro Marquez-OrtíziD· 3 shared Stella N. KoliavasiD· 3 shared David Ryan OrmondiD· 2 shared Karen L.F. Alvarez-ErasoiD· 2 shared Morgan S. FoxiD· 2 shared Peter KabosiD· 2 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Diana M. CittellyORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyNeuro-OncologyPeer-reviewedJul 28, 2026

Estradiol Reprograms Microglia to Create an Immune-Suppressed Niche Permissive to Breast Cancer Brain Metastasis

Karen L.F. Alvarez-Eraso, Maria Jose Contreras-Zarate, Andrew E. Goodspeed…·Diana M. Cittelly

This study shows estradiol suppresses microglial immunity and promotes breast cancer brain metastasis, with E2 suppression enhancing anti-tumor responses and synergizing with radiotherapy.

DOI 10.1093/neuonc/noag173

mousescRNA-seq

𝕏 PostBluesky

Cancer BiologyCancer Research CommunicationsPeer-reviewedJul 21, 2026

Targeting wild type NTRK decreases brain metastases of lung cancers non-driven by NTRK fusions

Maria Jose Contreras-Zarate, Jenny A. Jaramillo-Gómez, Ricaurte Alejandro Marquez-Ortíz…·Diana M. Cittelly

This study shows that NTRK inhibitors can reduce brain metastases in lung cancers with wild-type NTRK, even without NTRK fusions.

DOI 10.1158/2767-9764.crc-25-0811

humanproteomics

𝕏 PostBluesky

Cancer BiologyNature CommunicationsPeer-reviewedMay 28, 2026

Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of ER+ breast cancer brain metastases in young and aged hosts

Morgan S. Fox, Jenny A. Jaramillo-Gómez, Ricaurte Alejandro Marquez-Ortíz…·Diana M. Cittelly

This study shows FGFR1 amplification drives ER+ breast cancer brain metastasis in young and aged mice via FGF2 and NCAM1 interactions, with FGFR inhibitors effective in early stages.

DOI 10.1038/s41467-026-73726-5

mouseexperimental assay

𝕏 PostBluesky